Biocycive Inc.
Get Full AccessDescription
- BioCycive is wholly owned subsidiary of Globavir Biosciences Inc.Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually. Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients. Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.
-
Headquarters: , Los Altos, California, United States
More -
Phone Number:
-
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:Biocycive Inc.
-
Biocycive Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Biocycive Inc.
-
What is Biocycive Inc.'s Revenue?
Biocycive Inc.'s revenue is $1 - 10M
-
What is Biocycive Inc.'s NAICS code?
Biocycive Inc.'s NAICS code is 541713
-
How many employees are working in Biocycive Inc.
Biocycive Inc. has 3 employees
-
What is Biocycive Inc.'s Industry?
Biocycive Inc. is in the industry of Biotechnology
-
Who is Biocycive Inc.'s Senior Vice President And Head Of Medicinal Chemistry At Biocycive Inc?
Biocycive Inc.'s Senior Vice President And Head Of Medicinal Chemistry At Biocycive Inc is Chenera Balan